O

OrsoBio

11 employees

OrsoBio develops therapies to treat severe metabolic disorders, including type 2 diabetes, and other conditions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Biopharma

Date founded

2021

Funding rounds raised

Total raised

$2.3M

from 1 investors over 1 rounds

O

OrsoBio raised $2.3M on November 2, 2022

Investors: NIDDK, NIH

FAQ